Tag Archives: BCOV

Hot Warren Buffett Stocks To Own For 2021

PeepCoin (CURRENCY:PCN) traded 70.2% higher against the dollar during the 24-hour period ending at 13:00 PM ET on August 14th. During the last week, PeepCoin has traded 1.4% higher against the dollar. One PeepCoin coin can currently be bought for $0.0000 or 0.00000000 BTC on popular cryptocurrency exchanges including Trade Satoshi, CoinExchange, C-Patex and Cryptopia. PeepCoin has a total market cap of $497,805.00 and $5,648.00 worth of PeepCoin was traded on exchanges in the last 24 hours.

Here’s how other cryptocurrencies have performed during the last 24 hours:

Get PeepCoin alerts:

Aeternity (AE) traded 17.7% lower against the dollar and now trades at $0.89 or 0.00014709 BTC. Hshare (HSR) traded 18.2% lower against the dollar and now trades at $2.50 or 0.00041370 BTC. ARBITRAGE (ARB) traded down 8.9% against the dollar and now trades at $2.05 or 0.00033863 BTC. NevaCoin (NEVA) traded up 0.2% against the dollar and now trades at $0.0293 or 0.00000485 BTC. CryptoWorldX Token (CWXT) traded flat against the dollar and now trades at $0.0004 or 0.00000006 BTC. Axiom (AXIOM) traded down 3.9% against the dollar and now trades at $0.0070 or 0.00000115 BTC.

PeepCoin Profile

Hot Warren Buffett Stocks To Own For 2021: Intercept Pharmaceuticals, Inc.(ICPT)

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid, a bile acid analog, that completed Phase III clinical trials for the treatment of primary biliary cholangitis and Phase II clinical trials for the treatment of nonalcoholic fatty liver disease; and is in Phase III clinical trials for the treatment of nonalcoholic steatohepatitis, Phase II clinical trials for the treatments of primary sclerosing cholangitis, and Phase II clinical trial for the treatment of biliary atresia. The company is also developing INT-767, an orally administered dual FXR and TGR5 agonist, which is in Phase I clinical trial for the treatment of fibrosis; and INT-777, an orally administered TGR5 agonist that is in preclinical stage for the treatment of type 2 diabetes. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By George Budwell]

    Intercept Pharmaceuticals (NASDAQ:ICPT), a mid-cap drugmaker focusing on diseases of the liver, saw its shares lose 14.5% of their value last month,according to data fromS&P Global Market Intelligence. Prior to last month’s pullback, Intercept’s shares were up by almost 80% over the last 12 months.

  • [By Jon C. Ogg]

    Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) was last seen trading after the company’s financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall Street.

  • [By Motley Fool Transcribing]

    Intercept Pharmaceuticals (NASDAQ:ICPT) Q4 2018 Earnings Conference CallFeb. 28, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Hot Warren Buffett Stocks To Own For 2021: ImmuCell Corporation(ICCC)

ImmuCell Corporation was founded in 1982 and completed an initial public offering of common stock in 1987. After achieving approval from the U.S. Department of Agriculture (USDA) to sell First Defense庐 in 1991, we focused most of our efforts during the 1990’s developing human product applications of the underlying milk protein purification technology. Beginning in 1999, we re-focused our business strategy on First Defense庐 and other products for the dairy and beef industries. During the first quarter of 2016, we sold 1.1 million shares of common stock in an underwritten public offering registered with the Securities and Exchange Commission (SEC), raising net proceeds of $5.3 million. Our purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries.   Advisors’ Opinion:

  • [By Max Byerly]

    ImmuCell Co. (NASDAQ:ICCC) Director David Scott Tomsche purchased 3,000 shares of the firm’s stock in a transaction dated Thursday, August 16th. The stock was purchased at an average cost of $6.67 per share, with a total value of $20,010.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Stephan Byrd]

    ImmuCell (NASDAQ:ICCC) released its quarterly earnings results on Monday. The biotechnology company reported ($0.04) earnings per share for the quarter, Bloomberg Earnings reports. ImmuCell had a negative net margin of 1.61% and a negative return on equity of 0.79%.

Hot Warren Buffett Stocks To Own For 2021: Brightcove Inc.(BCOV)

Brightcove Inc., or Brightcove, is a leading global provider of cloud-based services for video. Brightcove was incorporated in Delaware in August 2004 and our headquarters are in Boston, Massachusetts. Our suite of products and services reduces the cost and complexity associated with publishing, distributing, measuring and monetizing video across devices.
Brightcove Video Cloud, or Video Cloud, our flagship product released in 2006, is the world’s leading online video platform. Video Cloud enables our customers to publish and distribute video to Internet-connected devices quickly, easily and in a cost-effective and high-quality manner. Brightcove Zencoder, or Zencoder, is a cloud-based video encoding service. Brightcove Once, or Once, is an innovative, cloud-based ad insertion and video stitching service that addresses the limitations of traditional online video ad insertion technology.   Advisors’ Opinion:

  • [By Logan Wallace]

    Brightcove (NASDAQ:BCOV) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Brightcove Inc (NASDAQ:BCOV)Q42018 Earnings Conference CallFeb. 13, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Warren Buffett Stocks To Own For 2021: Information Services Group Inc.(III)

Information Services Group, Inc. operates as a fact-based sourcing advisory company principally in the Americas, Europe, and the Asia Pacific. It provides strategic consulting, benchmarking and analytics, managed services, and research services with a focus on information technology, business process transformation, and enterprise resource planning. The company serves financial services, telecom, healthcare and pharmaceuticals, manufacturing, transportation and travel, and energy and utilities industries; and state and local governments and airport and transit authorities. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.

Advisors’ Opinion:

  • [By Logan Wallace]

    Canaccord Genuity upgraded shares of Imperial Metals (TSE:III) from a hold rating to a buy rating in a research note published on Monday. They currently have C$4.00 price objective on the stock, up from their prior price objective of C$1.65.

  • [By Logan Wallace]

    Martingale Asset Management L P bought a new position in Information Services Group, Inc. Common Stock (NASDAQ:III) during the second quarter, Holdings Channel reports. The fund bought 110,416 shares of the business services provider’s stock, valued at approximately $453,000.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Information Services Group, Inc. Common Stock (III)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Warren Buffett Stocks To Own For 2021: Corbus Pharmaceuticals Holdings, Inc.(CRBP)

Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat rare life-threatening inflammatory and fibrotic diseases. Its lead product candidate, Resunab, is a novel oral anti-inflammatory drug that is expected to commence Phase IIa clinical trials for the treatment of cystic fibrosis and diffuse systemic sclerosis diseases. The company is based in Norwood, Massachusetts.

Advisors’ Opinion:

  • [By Motley Fool Transcription]

    Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP)Q4 2018 Earnings Conference CallMarch 12, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Keith Speights]

    Biotech

    GW Pharmaceuticals (NASDAQ:GWPH) $3.7 billion

    Cara Therapeutics (NASDAQ: CARA) $697 million

    Insys Therapeutics (NASDAQ: INSY) $473 million

    22nd Century Group (NYSEMKT: XXII) $313 million

    Corbus Pharmaceuticals (NASDAQ: CRBP) $271 million

    Ancillary provider

  • [By Todd Campbell]

    ETFMG Alternative Harvest ETF

    Company Percent of Holdings
    Canopy Growth Corp. (NYSE:CGC) 9.85%
    Cronos Group Inc. (NASDAQ: CRON) 9.48%
    Aurora Cannabis Inc. (NASDAQOTH:ACBFF) 9.3%
    Tilray, Inc. (NASDAQ:TLRY) 9.2%
    GW Pharmaceuticals PLC (NASDAQ:GWPH) 6.78%
    CannTrust Holdings (NASDAQOTH: CNTTF) 4.63%
    Hydropothecary Corp. (NASDAQOTH: HYYDF) 4.56%
    Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) 3.46%
    Green Organic Dutchman Holding (NASDAQOTH: TGODF)

    3.36%

  • [By Keith Speights]

    Three of the biggest winners this week were Viking Therapeutics (NASDAQ:VKTX), Acadia Pharmaceuticals (NASDAQ:ACAD), and Corbus Pharmaceuticals (NASDAQ:CRBP). What drove these biotech stocks higher — and are they buys now?

Hot Warren Buffett Stocks To Own For 2021: Hudson Global, Inc.(HSON)

Hudson Global, Inc. provides professional-level recruitment and related talent solutions for small to large-sized corporations and government agencies worldwide. The company offers permanent recruitment services; and temporary contracting services, such as project management, interim management, and professional contract staffing services. It also offers recruitment process outsourcing services, such as complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting services to multinational companies; and talent management solutions, including talent assessment, interview training, executive coaching, employee development, and outplacement. The company was formerly known as Hudson Highland Group, Inc. and changed its name to Hudson Global, Inc. in April 2012. Hudson Global, Inc. was founded in 2003 and is based in New York, New York.

Advisors’ Opinion:

  • [By Shane Hupp]

    JBF Capital Inc. purchased a new position in Hudson Global Inc (NASDAQ:HSON) in the second quarter, Holdings Channel reports. The fund purchased 157,917 shares of the business services provider’s stock, valued at approximately $256,000.

Hot Canadian Stocks To Invest In 2019

What happened

Shares of Tilray, Inc. (NASDAQ:TLRY) were up 13.1% as of 11:22 a.m. EDT on Monday. A subsidiary of Tilray, High Park Farms, announced earlier in the morning that it had received a cannabis sales license from Health Canada. This license allows High Park to sell recreational marijuana products once the Canadian adult-use market opens on Oct. 17, 2018.

So what

Receiving the cannabis sales license was good news for Tilray. However, it wasn’t unexpected news. High Park Farms received its cultivation license in April 2018. It would have been much more surprising had High Park not also won the sales license.

Image source: Getty Images.

So why did Tilray’s share price jump so much on an announcement that pretty much everyone expected? We have to look back over the last several weeks to make sense of today’s big gain.

Hot Canadian Stocks To Invest In 2019: Brightcove Inc.(BCOV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern’s scoring:

    Get Brightcove alerts:

    Critical Analysis: Brightcove (BCOV) vs. Smartsheet (SMAR) (americanbankingnews.com) Brightcove (BCOV) PT Raised to $13.00 at Stifel Nicolaus (americanbankingnews.com) Brightcove Pushes the Envelope with Video Experiences that Increase Customer ROI (finance.yahoo.com) Brightcove Launches OTT Flow X, Powered by Accedo (finance.yahoo.com)

    A number of research analysts have recently issued reports on BCOV shares. Zacks Investment Research cut shares of Brightcove from a “buy” rating to a “hold” rating in a research note on Wednesday, April 25th. Dougherty & Co lifted their target price on shares of Brightcove from $11.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, May 17th. BidaskClub upgraded shares of Brightcove from a “hold” rating to a “buy” rating in a research report on Saturday, April 28th. TheStreet upgraded shares of Brightcove from a “d+” rating to a “c-” rating in a research report on Monday, May 7th. Finally, Stifel Nicolaus boosted their price objective on shares of Brightcove from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, May 22nd. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $9.85.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Brightcove (BCOV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Canadian Stocks To Invest In 2019: ABM Industries Incorporated(ABM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Private Advisor Group LLC boosted its stake in ABM Industries, Inc. (NYSE:ABM) by 886.5% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 106,750 shares of the business services provider’s stock after acquiring an additional 95,929 shares during the quarter. Private Advisor Group LLC’s holdings in ABM Industries were worth $3,119,000 at the end of the most recent reporting period.

  • [By Rich Smith]

    Shares of cleaning contractor ABM Industries (NYSE:ABM) — a big player in government contracting but an even bigger player in commercial cleaning — hopped 11% in early trading Friday before settling down to enjoy a still-respectable 8.7% gain as of 12:15 p.m. EDT.

  • [By Travis Hoium]

    Shares of ABM Industries, Inc. (NYSE:ABM) jumped as much as 13.4% in trading Thursday after the facility solutions provider reported fiscal second-quarter results that topped analyst expectations. The stock cooled off slightly at midday but was still up 11.3% at 11:05 a.m. EDT. 

  • [By Motley Fool Transcribing]

    ABM Industries (NYSE:ABM) Q3 2018 Earnings Conference CallSep. 7, 2018 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Shares of ABM Industries, Inc. (NYSE:ABM) rose 0.6% on Monday . The company traded as high as $35.06 and last traded at $34.08. Approximately 42,504 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 614,739 shares. The stock had previously closed at $33.87.

  • [By Logan Wallace]

    ABM Industries, Inc. (NYSE:ABM) insider Scott B. Salmirs sold 6,239 shares of the firm’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $33.98, for a total value of $212,001.22. Following the completion of the transaction, the insider now directly owns 120,693 shares in the company, valued at $4,101,148.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Hot Canadian Stocks To Invest In 2019: Oak Valley Bancorp (CA)(OVLY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Oak Valley Bancorp (NASDAQ:OVLY) Director H Randolph Holder, Jr. purchased 3,200 shares of the business’s stock in a transaction on Friday, May 18th. The shares were acquired at an average price of $20.00 per share, for a total transaction of $64,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Top Clean Energy Stocks To Invest In Right Now

While utilities are eager to clean up the power sector, they’re realizing that will be a difficult task for renewables alone to accomplish. Consider that, because power and energy aren’t the same thing, it takes 2 gigawatts (GW) of solar or 1.4 GW of wind to replace the electricity generated from every 1 GW of retired coal-fired capacity. That gap will close as technology improves, but time is of the essence to meet carbon emission reductions outlined in the Paris Agreement.

That helps to explain why many utilities are turning to one of the most important, lowest-cost, and most often overlooked clean energy technologies available: energy efficiency. Long-term investors should pay close attention, as the compounding synergies realized from pairing renewables with energy efficiency could differentiate the best utilities stocks to own from the rest of the pack.

Image source: Getty Images.

Top Clean Energy Stocks To Invest In Right Now: PennyMac Mortgage Investment Trust(PMT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) – Equities researchers at Wedbush lifted their Q1 2019 earnings per share estimates for shares of Pennymac Mortgage Investment in a research note issued to investors on Thursday, May 10th. Wedbush analyst J. Weaver now anticipates that the real estate investment trust will post earnings per share of $0.36 for the quarter, up from their previous estimate of $0.34. Wedbush also issued estimates for Pennymac Mortgage Investment’s Q2 2019 earnings at $0.43 EPS, Q3 2019 earnings at $0.43 EPS, Q4 2019 earnings at $0.52 EPS and FY2019 earnings at $1.74 EPS.

  • [By Stephan Byrd]

    Pennymac Mortgage Investment (NYSE:PMT) shares reached a new 52-week high and low on Monday . The company traded as low as $18.60 and last traded at $18.62, with a volume of 19306 shares changing hands. The stock had previously closed at $18.50.

Top Clean Energy Stocks To Invest In Right Now: Shaw Communications Inc.(SJR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shaw Communications (TSE:SJR.B) (NYSE:SJR) had its price objective boosted by analysts at National Bank Financial from C$28.00 to C$29.00 in a report issued on Wednesday. The firm currently has a “sector perform” rating on the stock. National Bank Financial’s price target would suggest a potential upside of 4.50% from the company’s current price.

  • [By Stephan Byrd]

    Shaw Communications Inc (TSE:SJR.B) (NYSE:SJR) announced a monthly dividend on Monday, May 14th, TickerTech reports. Stockholders of record on Wednesday, May 30th will be paid a dividend of 0.0988 per share on Wednesday, May 30th. This represents a $1.19 dividend on an annualized basis and a dividend yield of 4.57%. The ex-dividend date of this dividend is Monday, May 14th.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Shaw Communications Inc Class B (SJR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Shaw Communications (SJR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund]

    Let me introduce you to Canadian cable company Shaw Communications (NYSE:SJR), retail-focused REIT Realty Income (NYSE:O), and equity investment firm Main Street Capital (NYSE:MAIN). All of these companies send out monthly dividend payments.

Top Clean Energy Stocks To Invest In Right Now: Brightcove Inc.(BCOV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern’s scoring:

    Get Brightcove alerts:

    Critical Analysis: Brightcove (BCOV) vs. Smartsheet (SMAR) (americanbankingnews.com) Brightcove (BCOV) PT Raised to $13.00 at Stifel Nicolaus (americanbankingnews.com) Brightcove Pushes the Envelope with Video Experiences that Increase Customer ROI (finance.yahoo.com) Brightcove Launches OTT Flow X, Powered by Accedo (finance.yahoo.com)

    A number of research analysts have recently issued reports on BCOV shares. Zacks Investment Research cut shares of Brightcove from a “buy” rating to a “hold” rating in a research note on Wednesday, April 25th. Dougherty & Co lifted their target price on shares of Brightcove from $11.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, May 17th. BidaskClub upgraded shares of Brightcove from a “hold” rating to a “buy” rating in a research report on Saturday, April 28th. TheStreet upgraded shares of Brightcove from a “d+” rating to a “c-” rating in a research report on Monday, May 7th. Finally, Stifel Nicolaus boosted their price objective on shares of Brightcove from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, May 22nd. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $9.85.

Top Undervalued Stocks To Watch For 2019

Shares of Ford Motor Co. (NYSE: F) got a boost Wednesday after a rare “double upgrade” from Morgan Stanley (NYSE: MS).

After four years of bearish ratings for Ford stock, Morgan Stanley analyst Adam Jonas pushed the stock’s rating up two notches, calling it “overweight” – an indication that it’s undervalued. He set a price target of $15, compared to Tuesday’s closing price of $10.78.

Perhaps Morgan Stanley’s analysts have been reading Money Morning, because we’ve been telling people not to count Ford out for over a year.

In January of last year, Money Morning Executive Editor Bill Patalon recommended using an “accumulation mindset” toward Ford stock, buying a little bit at a time.

Top Undervalued Stocks To Watch For 2019: j2 Global, Inc.(JCOM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    J2 Global (NASDAQ:JCOM) Director W Brian Kretzmer sold 5,942 shares of the stock in a transaction on Wednesday, May 9th. The stock was sold at an average price of $87.25, for a total value of $518,439.50. Following the transaction, the director now owns 6,764 shares of the company’s stock, valued at $590,159. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Top Undervalued Stocks To Watch For 2019: Dawson Geophysical Company(DWSN)

Advisors’ Opinion:

  • [By Max Byerly]

    Dawson Geophysical (NASDAQ:DWSN) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Monday.

  • [By Logan Wallace]

    Dawson Geophysical (NASDAQ:DWSN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a research note issued on Monday.

Top Undervalued Stocks To Watch For 2019: Brightcove Inc.(BCOV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news headlines that may have effected Accern’s scoring:

    Get Brightcove alerts:

    Critical Analysis: Brightcove (BCOV) vs. Smartsheet (SMAR) (americanbankingnews.com) Brightcove (BCOV) PT Raised to $13.00 at Stifel Nicolaus (americanbankingnews.com) Brightcove Pushes the Envelope with Video Experiences that Increase Customer ROI (finance.yahoo.com) Brightcove Launches OTT Flow X, Powered by Accedo (finance.yahoo.com)

    A number of research analysts have recently issued reports on BCOV shares. Zacks Investment Research cut shares of Brightcove from a “buy” rating to a “hold” rating in a research note on Wednesday, April 25th. Dougherty & Co lifted their target price on shares of Brightcove from $11.00 to $14.00 and gave the company a “buy” rating in a research note on Thursday, May 17th. BidaskClub upgraded shares of Brightcove from a “hold” rating to a “buy” rating in a research report on Saturday, April 28th. TheStreet upgraded shares of Brightcove from a “d+” rating to a “c-” rating in a research report on Monday, May 7th. Finally, Stifel Nicolaus boosted their price objective on shares of Brightcove from $11.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, May 22nd. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $9.85.

Top Undervalued Stocks To Watch For 2019: Volkswagen Aktiengesellschaft (VLKAY)

Advisors’ Opinion:

  • [By ]

    I drove the QX30 for a few days and it was a bit of a doozy. The thing I like the most about the QX30 is its styling. It is basically a Volkswagen (OTCPK:VLKAY) (OTCPK:VLKAF) Golf type of a hatchback, but it looks very good, especially from the rear and from the rear profile. Very similar to the Mazda 3, it looks a lot wider than it is.

  • [By John Rosevear]

    BMW joins rival Volkswagen AG (NASDAQOTH:VLKAY) as a CATL customer. VW, which is expected to launch several battery-electric vehicles over the next couple of years, has signed battery contracts worth about $25 billion in total with CATL and two of its Korean rivals, LG Chem and Samsung SDI. Another BMW rival, Mercedes-Benz parent Daimler AG, said that it is in talks with CATL about buying batteries from the Erfurt plant.

  • [By John Rosevear]

    Under the deal, the two companies — and their affiliates, including Audi owner Volkswagen AG (NASDAQOTH:VLKAY) and Hyundai partner Kia Motors– will license key patents to one another and share access to fuel-cell parts, including the parts that Hyundai has developed for its current fuel-cell vehicles.

  • [By ]

    At the risk of reprising the Alteryx commercial which I have linked for the convenience of readers, people use Alteryx because it requires no coding, it can be used by non-full time data scientists, it has repeatable workflows and it integrates data from all kind of sources and is able to perform predictive, statistical, predictive and spatial analytics within the same workflow. Tableau can integrate data from multiple sources and send it to its engine where a visual representation can be made. It doesn’t do and isn’t designed to do the other things that Alteryx does. That is not a knock on Tableau. The fact that a VW (OTCPK:VLKAY) can’t deal with the same volume of freight when compared to a Mack Truck doesn’t mean that the VW isn’t “good” but it doesn’t work to haul heavy volumes of freight.

Top Undervalued Stocks To Watch For 2019: LifePoint Health, Inc.(LPNT)

Advisors’ Opinion:

  • [By Max Byerly]

    Headlines about LifePoint Health (NASDAQ:LPNT) have trended positive this week, Accern reports. The research firm scores the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a news impact score of 0.44 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.0016583450414 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Celgene Corporation (NASDAQ: CELG) is projected to report quarterly earnings at $1.96 per share on revenue of $3.46 billion.
    Aon plc (NYSE: AON) is expected to report quarterly earnings at $2.8 per share on revenue of $2.93 billion.
    American Axle & Manufacturing Holdings, Inc. (NYSE: AXL) is estimated to report quarterly earnings at $0.81 per share on revenue of $1.75 billion.
    Alibaba Group Holding Limited (NYSE: BABA) is expected to report quarterly earnings at $0.88 per share on revenue of $9.27 billion.
    LifePoint Health, Inc. (NASDAQ: LPNT) is projected to report quarterly earnings at $1.13 per share on revenue of $1.62 billion.
    V.F. Corporation (NYSE: VFC) is estimated to report quarterly earnings at $0.65 per share on revenue of $2.90 billion.
    Newell Brands Inc. (NYSE: NWL) is expected to report quarterly earnings at $0.26 per share on revenue of $3.05 billion.
    Titan International, Inc. (NYSE: TWI) is projected to report quarterly earnings at $0.04 per share on revenue of $407.27 million.
    Boise Cascade Company (NYSE: BCC) is expected to report quarterly earnings at $0.45 per share on revenue of $1.09 billion.
    Cheniere Energy, Inc. (NYSE: LNG) is estimated to report quarterly earnings at $0.39 per share on revenue of $1.59 billion.
    Cboe Global Markets, Inc. (NASDAQ: CBOE) is projected to report quarterly earnings at $1.24 per share on revenue of $308.05 million.
    ITT Inc. (NYSE: ITT) is estimated to report quarterly earnings at $0.73 per share on revenue of $683.96 million.
    Fred's, Inc. (NASDAQ: FRED) is expected to report quarterly loss at $0.19 per share on revenue of $551.00 million.
    Virtu Financial, Inc. (NASDAQ: VIRT) is projected to report quarterly earnings at $0.52 per share on revenue of $288.31 million.
    Cheniere Energy Partners, L.P. (NYSE: CQP) is expected to report quarterly earnings at $0.57 per share on revenue of $1.38 billion.
    Genesis Energy, L.P